Aducanumab: Appropriate Use Recommendations von Cummings, Jeffrey, Aisen, P., Apostolova, L. G., Atri, A., Salloway, S., Weiner, M.

Volltext

Lecanemab: Appropriate Use Recommendations von Cummings, J., Apostolova, L., Rabinovici, G. D., Atri, A., Aisen, P., Greenberg, S., Hendrix, S., Selkoe, D., Weiner, M., Petersen, R. C., Salloway, S.

Volltext

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease von Salloway, S, Sperling, R, Gilman, S, Fox, N C, Blennow, K, Raskind, M, Sabbagh, M, Honig, L S, Doody, R, van Dyck, C H, Mulnard, R, Barakos, J, Gregg, K M, Liu, E, Lieberburg, I, Schenk, D, Black, R, Grundman, M

Volltext

Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience von Greenberg, B D, Gabriels, L A, Malone, D A, Rezai, A R, Friehs, G M, Okun, M S, Shapira, N A, Foote, K D, Cosyns, P R, Kubu, C S, Malloy, P F, Salloway, S P, Giftakis, J E, Rise, M T, Machado, A G, Baker, K B, Stypulkowski, P H, Goodman, W K, Rasmussen, S A, Nuttin, B J

Volltext

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease von SALLOWAY, S, SPERLING, R, CRANS, G, LIANG, E, QUINN, G, BAIRU, M, PASTRAK, A, CEDARBAUM, J. M, KEREN, R, PORSTEINSSON, A. P, VAN DYCK, C. H, TARIOT, P. N, GILMAN, S, ARNOLD, D, ABUSHAKRA, S, HERNANDEZ, C

Volltext

Aducanumab: Appropriate Use Recommendations Update von Cummings, Jeffrey, Rabinovici, G. D., Atri, A., Aisen, P., Apostolova, L. G., Hendrix, S., Sabbagh, M., Selkoe, D., Weiner, M., Salloway, S.

Volltext

Gamma knife capsulotomy for intractable OCD: Neuroimage analysis of lesion size, location, and clinical response von McLaughlin, N. C. R., Magnotti, J. F., Banks, G. P., Nanda, P., Hoexter, M. Q., Lopes, A. C., Batistuzzo, M. C., Asaad, W. F., Stewart, C., Paulo, D., Noren, G., Greenberg, B. D., Malloy, P., Salloway, S., Correia, S., Pathak, Y., Sheehan, J., Marsland, R., Gorgulho, A., De Salles, A., Miguel, E. C., Rasmussen, S. A., Sheth, S. A.

Volltext

Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial von DOODY, R. S, FERRIS, S. H, SALLOWAY, S, SUN, Y, GOLDMAN, R, WATKINS, W. E, XU, Y, MURTHY, A. K

Volltext

Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial von SALLOWAY, S, FERRIS, S, KLUGER, A, GOLDMAN, R, GRIESING, T, KUMAR, D, RICHARDSON, S

Volltext

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial von Mills, S.M., Mallmann, J., Santacruz, A.M., Fuqua, A., Carril, M., Aisen, P.S., Althage, M.C., Belyew, S., Benzinger, T.L., Brooks, W.S., Buckles, V.D., Cairns, N.J., Clifford, D., Danek, A., Fagan, A.M., Farlow, M., Fox, N., Ghetti, B., Goate, A.M., Heinrichs, D., Hornbeck, R., Jack, C., Jucker, M., Klunk, W.E., Marcus, D.S., Martins, R.N., Masters, C.M., Mayeux, R., McDade, E., Morris, J.C., Oliver, A., Ringman, J.M., Rossor, M.N., Salloway, S., Schofield, P.R., Snider, J., Snyder, P., Sperling, R.A., Stewart, C., Thomas, R.G., Xiong, C., Bateman, R.J.

Volltext

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval von Howe, Matthew D., Britton, K. J., Joyce, H. E., Pappas, G. J., Faust, M. A., Dawson, B. C., Riddle, M. C., Salloway, S. P.

Volltext

The Future of Anti-Amyloid Trials von Aisen, P. S., Cummings, J., Doody, R., Kramer, L., Salloway, S., Selkoe, D. J., Sims, J., Sperling, R. A., Vellas, B.

Volltext

MR imaging features of amyloid-related imaging abnormalities von Barakos, J, Sperling, R, Salloway, S, Jack, C, Gass, A, Fiebach, J B, Tampieri, D, Melançon, D, Miaux, Y, Rippon, G, Black, R, Lu, Y, Brashear, H R, Arrighi, H M, Morris, K A, Grundman, M

Volltext

Galantamine treatment of vascular dementia : A randomized trial von AUCHUS, A. P, BRASHEAR, H. R, SALLOWAY, S, KORCZYN, A. D, DE DEYN, P. P, GASSMANN-MAYER, C

Volltext

The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer’s Prevention Registry von Lee, Athene K. W., Collier, M. K., Thompson, L. I., Popescu, D., Arthur, E., Correia, S., Salloway, S. P., Alber, J.

Volltext

Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report von Bateman, Randall J., Blennow, K., Doody, R., Hendrix, S., Lovestone, S., Salloway, S., Schindler, R., Weiner, M., Zetterberg, H., Aisen, P., Vellas, B.

Volltext

Alzheimer’s Disease Clinical Trial Research Adaptation Following COVID-19 Pandemic Onset: National Sample of Alzheimer’s Clinical Trial Consortium Sites von Rhodus, Elizabeth K., Aisen, P., Grill, J. D., Rentz, D. M., Petersen, R. C., Sperling, R. A., Salloway, S. P., Pierce, D., Raman, R.

Volltext

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force von Angioni, D., Hansson, O., Bateman, R. J., Rabe, C., Toloue, M., Braunstein, J. B., Agus, S., Sims, J. R., Bittner, T., Carrillo, M. C., Fillit, H., Masters, C. L., Salloway, S., Aisen, P., Weiner, M., Vellas, B., Gauthier, S., Abushakra, Susan, Afshar, Mohammad, Alam, John, Algeciras-Schimnich, Alicia, Andrieu, Sandrine, Ballard, Clive, Baruch, Amos, Batrla, Richard, Baudler, Monika, Bell, Joanne, Bozeat, Sasha, Brooks, Dawn, Brooks, Tricia, Bullain, Szofia, Burmeister, Jan, Cho, Min, Collins, Emily, Cook, Gavin, Cummings, Jeffrey, Dague, Chris, De Santi, Susan, Doody, Rachelle, Dunn, Billy, Egan, Michael, Eriksson, Sven, Esquivel, Rianne, Fagan, Tom, Ferrell, Phyllis, Gallagher, Michela, Grönblad, Anna-Kaija, Hains, Avis, Hampel, Harald, Hefting, Nanco, Hendrix, Suzanne, Ho, Carole, Hu, Helen, Ismail, Zahinoor, Jones, Daryl, Kinney, Gene, Kinnon, Paul, Kurzman, Ricky, Lannfelt, Lars, Lawson, John, LeBastard, Nathalie, Lewandowski, Nicole, Lim, Carine, Lyketsos, Costantine, Masterman, Donna, Lu, Ming, Mintun, Mark, Molinuevo, José Luis, Monteiro, Cecilia, Navia, Bradford, Odergren, Tomas, Osswald, Gunilla, Penny, Lewis, Pontecorvo, Michael, Porsteinsson, Anton, Raman, Rema, Respondek, Gesine, Reyderman, Larisa, Rogers, Sharon, Rosenberg, Paul, Rosenzweig-Lipson, Sharon, Roskey, Mark, Saad, Ziad, Schindler, Rachel, Selkoe, Dennis, Shulman, Melanie, Sink, Kaycee, Sipe, Lisa, Skovronsky, Daniel, Somers, Elizabeth, Soto, Maria, Streffer, Johannes, Such, Pedro, Suhy, Joyce, Touchon, Jacques, Vandijck, Manu, White, Anne, Wilson, David, Zago, Wagner, Zhou, Jin

Volltext

Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/US CTAD Task Force von Gauthier, Serge, Alam, J., Fillit, H., Iwatsubo, T., Liu-Seifert, H., Sabbagh, M., Salloway, S., Sampaio, C., Sims, J. R., Sperling, B., Sperling, R., Welsh-Bohmer, K. A., Touchon, J., Vellas, B., Aisen, P.

Volltext

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease von Hansson, Oskar, Edelmayer, Rebecca M., Boxer, Adam L., Carrillo, Maria C., Mielke, Michelle M., Rabinovici, Gil D., Salloway, Stephen, Sperling, Reisa, Zetterberg, Henrik, Teunissen, Charlotte E.

Volltext